Archives of Pediatric Infectious Diseases

Published by: Kowsar

Association Between Cytokine Gene Polymorphisms and Human Susceptibility to Brucellosis

Faezeh Kabiri 1 , Ramazan Rajabnia 2 , Abazar Pournajaf 3 , Mehrdad Gholami 3 , Meysam Hasannejad Bibalan 3 , Aziz Kassani 4 , Sajad Yaghoubi 5 and Abdollah Ardebili 6 , 7 , *
Authors Information
1 Faculty of Dentistry, Qom University of Medical Sciences, Qom, IR Iran
2 Department of Microbiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, IR Iran
3 Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, IR Iran
5 Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
6 Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, IR Iran
7 Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: July 2017, 5 (3); e57274
  • Published Online: July 7, 2017
  • Article Type: Research Article
  • Received: August 21, 2016
  • Revised: January 9, 2016
  • Accepted: June 16, 2017
  • DOI: 10.5812/pedinfect.57274

To Cite: Kabiri F, Rajabnia R, Pournajaf A, Gholami M, Hasannejad Bibalan M, et al. Association Between Cytokine Gene Polymorphisms and Human Susceptibility to Brucellosis, Arch Pediatr Infect Dis. 2017 ; 5(3):e57274. doi: 10.5812/pedinfect.57274.

Abstract
Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Guerra H. The brucellae and their success as pathogens. Crit Rev Microbiol. 2007; 33(4): 325-31[DOI][PubMed]
  • 2. Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012; 6(10)[DOI][PubMed]
  • 3. Diaz Aparicio E. Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus. Rev Sci Tech. 2013; 32(1): 43-51[DOI][PubMed]
  • 4. Pappas G, Memish ZA. Brucellosis in the middle East: a persistent medical, socioeconomic and political issue. J Chemother. 2007; 19(3): 243-8[DOI][PubMed]
  • 5. Gwida M, Al Dahouk S, Melzer F, Rosler U, Neubauer H, Tomaso H. Brucellosis - regionally emerging zoonotic disease? Croat Med J. 2010; 51(4): 289-95[DOI][PubMed]
  • 6. Eini P, Keramat F, Hasanzadehhoseinabadi M. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran. J Res Health Sci. 2012; 12(2): 105-8[PubMed]
  • 7. von Bargen K, Gorvel JP, Salcedo SP. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev. 2012; 36(3): 533-62[DOI][PubMed]
  • 8. Rodriguez-Zapata M, Matias MJ, Prieto A, Jonde MA, Monserrat J, Sanchez L, et al. Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function. Infect Immun. 2010; 78(7): 3272-9[DOI][PubMed]
  • 9. Davoudi S, Amirzargar AA, Hajiabdolbaghi M, Rasoolinejad M, Soodbakhsh A, Jafari S, et al. Th-1 cytokines gene polymorphism in human brucellosis. Int J Immunogenet. 2006; 33(5): 355-9[DOI][PubMed]
  • 10. Kazemi S, Saidijam M, Hashemi SH, Karami M, Vaisi-Raygani A, Alikhani MY. Analysis of IL-10 and IL-6 Gene Polymorphisms and Their Serum Levels in Patients with Brucellosis: A Case Control Study. Immunol Invest. 2016; 45(2): 107-15[DOI][PubMed]
  • 11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215[DOI][PubMed]
  • 12. Lakhanpal M, Singh LC, Rahman T, Sharma J, Singh MM, Kataki AC, et al. Study of single nucleotide polymorphisms of tumour necrosis factors and HSP genes in nasopharyngeal carcinoma in North East India. Tumour Biol. 2016; 37(1): 271-81[DOI][PubMed]
  • 13. Gonen-Korkmaz C, Sevin G, Gokce G, Arun MZ, Yetik-Anacak G, Yildirim G, et al. Different responses of RT-PCR amplifications after tumor necrosis alpha (TNFa) induction at nuclear factor kappa B (NFkB) gene silenced LNCaP cells. FASEB J. 2013; 27(1 Supplement): 1105.7
  • 14. Furini AA, Capobianco MP, Storti-Melo LM, Cunha MG, Cassiano GC, Machado RL. Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon. Malar J. 2016; 15(1): 374[DOI][PubMed]
  • 15. Ding Q, Shi Y, Fan B, Fan Z, Ding L, Li F, et al. The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls. PLoS One. 2013; 8(2)[DOI][PubMed]
  • 16. Sortica VA, Cunha MG, Ohnishi MD, Souza JM, Ribeiro-Dos-Santos AK, Santos NP, et al. IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil. Malar J. 2012; 11: 409[DOI][PubMed]
  • 17. Pavkova Goldbergova M, Nemec P, Lipkova J, Jarkovsky J, Gatterova J, Ambrozkova D, et al. Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity. Int J Immunogenet. 2014; 41(1): 34-40[DOI][PubMed]
  • 18. Wang M, Zhu XY, Wang L, Lin Y. The -607C/A polymorphisms in interleukin-18 gene promoter contributes to cancer risk: evidence from a meta-analysis of 22 case-control studies. PLoS One. 2013; 8(10)[DOI][PubMed]
  • 19. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol. 2003; 98(1): 144-50[DOI][PubMed]
  • 20. Bravo MJ, de Dios Colmenero J, Alonso A, Caballero A. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Eur J Immunogenet. 2003; 30(6): 433-5[DOI][PubMed]
  • 21. Budak F, Goral G, Heper Y, Yilmaz E, Aymak F, Basturk B, et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine. 2007; 38(1): 32-6[DOI][PubMed]
  • 22. Kalani M, Rasouli M, Moravej A, Kiany S, Rahimi HR. Association of interleukin-15 single nucleotide polymorphisms with resistance to brucellosis among Iranian patients. Tissue Antigens. 2011; 78(5): 352-8[DOI][PubMed]
  • 23. Folwaczny M, Glas J, Torok HP, Tonenchi L, Paschos E, Bauer B, et al. Polymorphisms of the interleukin-18 gene in periodontitis patients. J Clin Periodontol. 2005; 32(5): 530-4[DOI][PubMed]
  • 24. Kamali-Sarvestani E, Rasouli M, Mortazavi H, Gharesi-Fard B. Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine. 2006; 35(3-4): 159-65[DOI][PubMed]
  • 25. Rasouli M, Kiany S, Moravej A, Kalani M. Interleukin-12 and tumor necrosis factor-β gene polymorphisms as genetic susceptibility factors for brucellosis in Iranian patients. Iran Red Crescent Med J. 2010; 2010(3): 266-71
  • 26. Reza JS, Alireza R, Mostafa A, Alireza K, Mehrdad H. Association of tumor necrosis factor-alpha-308 (G-->A) polymorphism and susceptibility to brucellosis. J Microbiol Immunol Infect. 2009; 42(1): 22-6[PubMed]
  • 27. Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol. 2000; 121(3): 480-3[DOI][PubMed]
  • 28. Sathiyaseelan J, Goenka R, Parent M, Benson RM, Murphy EA, Fernandes DM, et al. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity. Cell Immunol. 2006; 243(1): 1-9[DOI][PubMed]
  • 29. Jubier-Maurin V, Boigegrain RA, Cloeckaert A, Gross A, Alvarez-Martinez MT, Terraza A, et al. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect Immun. 2001; 69(8): 4823-30[DOI][PubMed]
  • 30. Karaoglan I, Pehlivan S, Namiduru M, Pehlivan M, Kilincarslan C, Balkan Y, et al. TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis. New Microbiol. 2009; 32(2): 173-8[PubMed]
  • 31. Yoshikai Y, Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect. 2000; 2(4): 381-9[DOI][PubMed]
  • 32. Rasouli M, Kalani M, Moravej A, Kiany S. Interleukin-18 single nucleotide polymorphisms contribute to the susceptibility to brucellosis in Iranian patients. Cytokine. 2011; 54(3): 272-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments